Meilandt W, Cisse M, Ho K, Wu T, Esposito L, Scearce-Levie K, Cheng I, Yu G.-Q, Mucke L. (2009) Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic AΒ oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J. Neurosci 29:1977-1986.
Sanchez-Mejia RO, Newman JW, Toh S, Yu G.-Q, Zhou Y, Halabisky B, Cisse M, Scearce-Levie K, Cheng IH, Gan L, Palop JJ, Bonventre JV, Mucke L. (2008) Phospholipase A2 reduction ameliorates cognitve deficits in mouse model of Alzheimer's disease. Nat. Neurosci. 11:1311-1318
Sun B, Zhou Y, Halabisky B, Lo I, Cho SH, Mueller-Steiner S, Devidze N, Wang X, Grubb A, Gan L. (2008) Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 60:247–257.
Zhong N, Scearce-Levie K, Ramaswamy G, Weisgraber KH. (2008) Apolipoprotein E4 domain interation: Synaptic and cognitive deficits in mice. Alzheimer's Dementia 4:179–192.
Meilandt WJ, Yu GQ, Chin J, Roberson ED, Palop JJ, Wu T, Scearce-Levie K, Mucke L (2008) Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 28:5007-5017.
Scearce-Levie K, Roberson ED, Gerstein H, Cholfin JA, Mandiyan VS, Shah NM, Rubenstein JL, Mucke L (2008) Abnormal social behaviors in mice lacking Fgf17. Genes Brain Behav. 7:344-354.
Deipolyi AR, Fang S, Palop JJ, Yu GQ, Wang X, Mucke L (2008) Altered navigational strategy use and visuospatial deficits in hAPP transgenic mice. Neurobiol. Aging . 29:253-266.
Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puoliväli J, Lesné S, Ashe KH, Muchowski PJ, Mucke L (2007) Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 282:23818-23828.
Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 316:750-754.
Esposito L, Raber J, Kekonius L, Yan F, Yu GQ, Bien-Ly N, Puoliväli J, Scearce-Levie K, Masliah E, Mucke L (2006) Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 26:5167-5179.
Chin J, Palop JJ, Puoliväli J, Massaro C, Bien-Ly N, Gerstein H, Scearce-Levie K, Masliah E, Mucke L (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 25:9694–9703.
Palop JJ, Chin J, Bien-Ly N, Massaro C, Yeung BZ, Yu G-Q, Mucke L (2005) Vulnerability of dentate granule cells to disruption of Arc expression in human amyloid precursor protein transgenic mice. J. Neurosci. I25:9686–9693.
Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, Wyss-Coray T, Fish JD, Masliah E, Hopkins PC, Scearce-Levie K, Weisgraber KH, Mucke L, Mahley RW, Huang Y (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl. Acad. Sci. USA 100:10966-10971.
Palop J, Jones B, Kekonius L, Chin J, Yu G-Q, Raber J, Masliah E, Mucke L (2003) Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer’s disease-related cognitive deficits. Proc. Natl. Acad. Sci. USA 100:9572–9577.
Raber J, Bongers G, LeFevour A, Buttini M, Mucke L (2002) Androgens protect against apoE4-induced cognitive deficits. J. Neurosci. 22:5204–5209.
Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, and Mucke L (2001) β-amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer’s disease and Parkinson’s disease. Proc. Natl. Acad. Sci. USA 98:12245–12250.
Raber J, Akana SF, Bhatnagar S, Dallman MF, Wong D, Mucke L (2000) Hypothalamic-pituitary-adrenal dysfunction in Apoe-/- mice: Possible role in behavioral and metabolic alterations. J. Neurosci. 20:2064–2071.
Raber J, Wong D, Yu G-Q, Buttini M, Mahley RW, Pitas RE, Mucke L (2000) Alzheimer’s disease: Apolipoprotein E and cognitive performance. Nature 404:352–354.
Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in Apoe knockout mice–Increased susceptibility of females. Proc. Natl. Acad. Sci. USA 95:10914–10919.
